Bhatti Featured in Duke Neurology Research Round-Up

Wednesday, November 1, 2017

Over the past 20 years, there have been many new advances in molecularly targeted therapies for cancer; however these advances have brought with them a variety of side effects, toxicity reactions, and other health concerns. M. Tariq Bhatti, MD, was the lead author of a review article examining these advances as well as the main neuro-opthalmic health concerns associated with them. Read that article in Eye here.

This was an expert from the original blog post.  Read the entire Duke Neurology Research Round-Up